THC Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
THC Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • THC Therapeutics, Inc. Operating Income (Loss) for the quarter ending January 31, 2024 was -$85.2K, a 68.9% increase year-over-year.
  • THC Therapeutics, Inc. Operating Income (Loss) for the twelve months ending January 31, 2024 was -$253K, a 75.6% increase year-over-year.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$494K, a 71.7% increase from 2022.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.75M, a 85.8% decline from 2021.
  • THC Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$940K, a 32.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$494K +$1.25M +71.7% Aug 1, 2022 Jul 31, 2023 10-K 2024-02-26
2022 -$1.75M -$806K -85.8% Aug 1, 2021 Jul 31, 2022 10-K 2024-02-26
2021 -$940K +$450K +32.4% Aug 1, 2020 Jul 31, 2021 10-K 2022-11-25
2020 -$1.39M +$25.3M +94.8% Aug 1, 2019 Jul 31, 2020 10-K 2022-03-31
2019 -$26.7M -$20.7M -345% Aug 1, 2018 Jul 31, 2019 10-K 2020-11-04
2018 -$5.99M Aug 1, 2017 Jul 31, 2018 10-K/A 2019-11-18
2013 -$365K -$124K -51.7% Aug 1, 2012 Jul 31, 2013 10-K 2014-06-09
2012 -$240K -$217K -920% Aug 1, 2011 Jul 31, 2012 10-K 2014-06-09
2011 -$23.6K Aug 1, 2010 Jul 31, 2011 10-K 2012-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.